Concepedia

Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma

Fan Feng, Qiyu Jiang, Shuang Cao, Yu Cao, Ruisheng Li, Lijun Shen, Hua Zhu, Tao Wang, Lijun Sun, Erguang Liang,

Biochimica et Biophysica Acta (BBA) - General Subjects · 2018 · 106 citations · 63 references

DOI

Concepts

References

63

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro et al. · New England Journal of Medicine · 2008 · 13K citations · Full text

, , +12

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen et al. · The Lancet Oncology · 2008 · 5.8K citations

, , +11

Sorafenib in Advanced Hepatocellular Carcinoma

재연 정 · 2008 · 5.6K citations

, , +12

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients

Yoichi Nagata, Keng‐Hsueh Lan, Xiaoyan Zhou et al. · Cancer Cell · 2004 · 1.9K citations · Full text

, , +14

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Theodore S. Hong, Jennifer Y. Wo, Beow Y. Yeap et al. · Journal of Clinical Oncology · 2015 · 470 citations

, , +17